Clinical implications for the use of a biomarker for subclinical rejection - Conflating arguments cause a disconnection between the premise and the conclusion

John Friedewald, Michael Abecassis, John Friedewald, Michael Abecassis

No abstract available

Keywords: biomarker; kidney transplantation/nephrology; rejection: subclinical; translational research/science.